Deals

Can-Fite BioPharma Raises $5M at 12% Discount via Roth Capital

By |

Can-Fite BioPharma Limited (CANF) announced that it has raised $5,059,072 in a Common Stock transaction. The common stock was sold at $5.15 per share, an approximate 12% discount to the market price ($5.85) of CANF at deal announcement. A series of 491,172 4.5-Month Warrants with an exercise price of $6.43 per share (9.91% premium) was issued to the investors in this transaction. Roth Capital Partners acted as the exclusive agent on the transaction. Placement Agent counsel was Schulte Roth & Zabel and issuer counsel was Sichenzia Ross Friedman Ference.

Deals

Catasys Raises $1M at 56% Discount from Crede CG

By |

Catasys, Inc. (CATS) announced that it has raised $1,000,002 in a Common Stock transaction. The common stock was sold at $0.58 per share, an approximate 56% discount to the market price ($1.33) of CATS at deal announcement. A series of 1,724,141 60-Month Warrants with an exercise price of $0.58 per share (56.39% discount) was issued to the investors in this transaction. The investors include Crede CG III, Limited. Issuer counsel was Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, PC.

Deals

Torchlight Energy Raises $7M at 16% Discount via National Securities Corp.

By |

Torchlight Energy Resources, Inc. (TRCH) announced that it has raised $7,000,000 in a Units (Common Stock + Warrants) transaction. The common stock was sold at $4.00 per share, an approximate 16% discount to the market price ($4.74) of TRCH at deal announcement. A series of 437,541 60-Month Warrants with an exercise price of $6.00 per share (26.58% premium) was issued to the investors in this transaction. National Securities Corporation acted as the exclusive agent on the transaction. The transaction closed on December 31, 2013.

Deals

Regado Bioscience Raises $20M at 20% Discount via Cowen, BMO

By |

Regado Bioscience, Inc. (RGDO) announced that it has raised $20,000,000 in a Common Stock transaction. The common stock was sold at $5.00 per share, an approximate 20% discount to the market price ($6.25) of RGDO at deal announcement. Cowen and Company, LLC acted as the Lead Agent with BMO Capital Markets Corp. acting as Co-Agent on the transaction. Issuer counsel was Lowenstein Sandler, PC and Goodwin Procter was Placement Agent Counsel. Note this Placement is subject to customary closing conditions and is expected to close by 02/05/2014. via PlacementTracker.